PTHL

6-K - Pheton Holdings Ltd (0001970544) (Filer)

BEIJING, China, Jan. 13, 2026 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, announced today that it will change its corporate name to iTonic Holdings Ltd, and change its stock ticker symbol to "ITOC" (collectively, the "Corporate Events"). The Company anticipates that the Corporate Events will be effective upon the commencement of trading on the Nasdaq Capital Market on January 16, 2026 (U.S. Eastern Time), at which time the Company's Class A ordinary shares will cease trading under the current ticker symbol "PTHL" and will begin tradi

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

Beijing, China, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ:PTHL) ("Pheton" or the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the successful completion of its acquisition of 51% of the total outstanding shares of iTonic Corporation (the "Target"), a U.S.-based integrated home health AI company that combines AI, medical device automation, and easier access to clinical expertise to support continuity of care in the home (the "Share Acquisition"). This strategic acquisition aligns with the Company's commitment to enhancing its portfolio in the healthcare tech

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

Beijing, China, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (NASDAQ:PTHL) (the "Company"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced, on October 20, 2025, the Company received a letter from the Listing Qualifications Department of The Nasdaq Stock Market LLC ("Nasdaq") notifying the Company that based on the closing bid price of the Class A ordinary shares of the Company for the last 30 consecutive business days, the Company no longer meets the continued listing requirement of Nasdaq under Nasdaq Listing Rules 5550(a)(2), to maintain a minimum bid price of $1 per share. Th

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company," "we," "our" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today issued the following statements in response to recent market volatility and a third-party publication that has raised questions and concerns among shareholders. Over the past few days, shares of Pheton have experienced an extraordinary and unexpected decline in its share price, which the Company believes may have been triggered by a speculative article published by The Bear Cave on July 29, 2025. The article asserts that Pheton's share price

SCHEDULE 13G - Pheton Holdings Ltd (0001970544) (Subject)

S-8 - Pheton Holdings Ltd (0001970544) (Filer)

20-F - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

6-K - Pheton Holdings Ltd (0001970544) (Filer)

BEIJING, China, Sept. 06, 2024 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the "Company" or "Pheton"), a healthcare solution provider specializing in treatment planning systems for brachytherapy and other related products and services, today announced the closing of its initial public offering (the "Offering") of 2,250,000 Class A ordinary shares at a public offering price of $4.00 per share, for total gross proceeds of $9 million, before deducting underwriting discounts and other related expenses. The Company has granted the underwriters an option, exercisable within 45 days from the closing date of the Offering, to purchase up to an additional 337,500 Class A ordinary shares at the initi

424B4 - Pheton Holdings Ltd (0001970544) (Filer)